Since glucose oxidation is suppressed in insulin resistant NAFLD patients and β-oxidation is upregulated, the periportal zonation of oxidative phosphorylation enzymes, along with those mediating β-oxidation, had an even larger effect on the simulated rate of oxidation of hepatic FFAs. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.